SEC Comment Letter for Perspective Therapeutics, Inc. (CATX) (CIK 0000728387) (CATX) — Jan 30, 2020
Perspective Therapeutics, Inc. (CATX) (CIK 0000728387)
Date: Jan. 30, 2020 · CIK: 0000728387 · Accession: 0000000000-20-000850
AI Filing Summary & Sentiment
File numbers found in text: 333-236025
Letter
January 30, 2020 Lori A. Woods Chief Executive Officer Isoray, Inc. 350 Hills Street, Suite 106 Richland, Washington 99354 Re:Isoray, Inc. Registration Statement on Form S-3 Filed January 23, 2020 File No. 333-236025 Dear Ms. Woods: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stephen R. Boatwright, Esq.
Show Raw Text
January 30, 2020
Lori A. Woods
Chief Executive Officer
Isoray, Inc.
350 Hills Street, Suite 106
Richland, Washington 99354
Re:Isoray, Inc.
Registration Statement on Form S-3
Filed January 23, 2020
File No. 333-236025
Dear Ms. Woods:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Stephen R. Boatwright, Esq.